Eikon Therapeutics, EIK1006, Prostate Cancer, Androgen Receptor Antagonist, IND Submission, Oncology, Drug Discovery, Advanced Imaging, Cancer Research, Clinical Development

MILLBRAE, Calif., October 15, 2026 Eikon Therapeutics, Inc. announced that it has submitted an Investigational New Drug (IND) application...